Search Results - "Liss, Gary"

Platelet-activating factor, histamine, and tryptase levels in human anaphylaxis by Vadas, Peter, MD, PhD, Perelman, Boris, PhD, Liss, Gary, MD, MS

“…Background Platelet-activating factor (PAF) is an important mediator and correlates with anaphylaxis severity. How well PAF correlates with severity relative…”
Get full text

Risk factors for fatal and nonfatal reactions to immunotherapy (2008-2018): postinjection monitoring and severe asthma by Epstein, Tolly G., Murphy-Berendts, Karen, Liss, Gary M., Bernstein, David I.

“…Subcutaneous allergen immunotherapy (SCIT) is highly effective but risks exist. To identify practices that influence systemic allergic reactions (SRs) to SCIT…”
Get full text

Risk factors for fatal and nonfatal reactions to subcutaneous immunotherapy: National surveillance study on allergen immunotherapy (2008-2013) by Epstein, Tolly G, Liss, Gary M, Murphy-Berendts, Karen, Bernstein, David I

“…In 2008, an annual surveillance study of systemic reactions (SRs) from subcutaneous immunotherapy (SCIT) injections was initiated in North America. To define…”
Get full text

AAAAI/ACAAI Subcutaneous Immunotherapy Surveillance Study (2013-2017): Fatalities, Infections, Delayed Reactions, and Use of Epinephrine Autoinjectors by Epstein, Tolly G., Liss, Gary M., Berendts, Karen Murphy, Bernstein, David I.

“…Subcutaneous allergen immunotherapy (SCIT) is highly effective but safety risks exist. The aims of this study were to: (1) identify clinical practices that…”
Get full text

Platelet-Activating Factor, PAF Acetylhydrolase, and Severe Anaphylaxis by Vadas, Peter, Gold, Milton, Perelman, Boris, Liss, Gary M, Lack, Gideon, Blyth, Thomas, Simons, F. Estelle R, Simons, Keith J, Cass, Dan, Yeung, Jupiter

“…Platelet-activating factor (PAF) is an anaphylactic mediator that is degraded in the blood by the enzyme PAF acetylhydrolase. In this study, patients with…”
Get full text

Risk factors for fatal and nonfatal reactions to subcutaneous immunotherapy by Epstein, Tolly G., MD, MS, Liss, Gary M., MD, MS, Murphy-Berendts, Karen, BS, Bernstein, David I., MD

“…Abstract Background In 2008, an annual surveillance study of systemic reactions (SRs) from subcutaneous immunotherapy (SCIT) injections was initiated in North…”
Get full text

AAAAI/ACAAI Surveillance Study of Subcutaneous Immunotherapy, Years 2008-2012: An Update on Fatal and Nonfatal Systemic Allergic Reactions by Epstein, Tolly G., MD, MS, Liss, Gary M., MD, MS, Murphy-Berendts, Karen, BS, RRT, CCRC, Bernstein, David I., MD

“…Background Before 2002, there were an estimated 3.4 fatal reactions per year to subcutaneous allergen immunotherapy (SCIT). Recent incidences of SCIT-related…”
Get full text

Diagnosis and management of work-related asthma: American College Of Chest Physicians Consensus Statement by Tarlo, Susan M, Balmes, John, Balkissoon, Ronald, Beach, Jeremy, Beckett, William, Bernstein, David, Blanc, Paul D, Brooks, Stuart M, Cowl, Clayton T, Daroowalla, Feroza, Harber, Philip, Lemiere, Catherine, Liss, Gary M, Pacheco, Karin A, Redlich, Carrie A, Rowe, Brian, Heitzer, Julia

“…A previous American College of Chest Physicians Consensus Statement on asthma in the workplace was published in 1995. The current Consensus Statement updates…”
Get more information

Immediate and delayed-onset systemic reactions after subcutaneous immunotherapy injections: ACAAI/AAAAI surveillance study of subcutaneous immunotherapy–year 2 by Epstein, Tolly G., MD, MS, Liss, Gary M., MD, MS, Murphy-Berendts, Karen, BS, Bernstein, David I., MD

“…Background Incidences of subcutaneous immunotherapy (SCIT) related systemic reactions (SRs) and fatal reactions (FRs) are not well defined, nor are…”
Get full text

AAAAI and ACAAI surveillance study of subcutaneous immunotherapy, Year 3: what practices modify the risk of systemic reactions? by Epstein, Tolly G., MD, MS, Liss, Gary M., MD, MS, Murphy-Berendts, Karen, BS, Bernstein, David I., MD

“…Abstract Objective To define the incidence of and clinical practices associated with subcutaneous immunotherapy (SCIT)–related systemic reactions (SRs)…”
Get full text

Cleaning agent usage in healthcare professionals and relationship to lung and skin symptoms by Garrido, Ameth N., House, Ronald, Lipszyc, Joshua C., Liss, Gary M., Holness, Dorothy Linn, Tarlo, Susan M.

“…Healthcare workers have an increased risk of respiratory symptoms and dermatitis, likely related to cleaning/disinfecting agents. The aim of this study was to…”
Get full text

Twelve-year survey of fatal reactions to allergen injections and skin testing: 1990-2001 by Bernstein, David I., Wanner, Mark, Borish, Larry, Liss, Gary M., the Immunotherapy Committee of the American Academy of Allergy, Asthma and Immunology

“…Fatal reactions associated with skin testing and injection immunotherapy have not been surveyed in North America since 1989. A survey of fatal reactions…”
Get full text

Surveillance of systemic reactions to subcutaneous immunotherapy injections: year 1 outcomes of the ACAAI and AAAAI Collaborative Study by Bernstein, David I., MD, Epstein, Tolly, MD, MS, Murphy-Berendts, Karen, BS, Liss, Gary M., MD, MS

“…Background Although systemic reactions (SRs) to subcutaneous immunotherapy (SCIT) injections are not uncommon, life-threatening and fatal reactions are rare…”
Get full text

Evaluation of Risk Factors for Infections and Systemic Reactions (SRs) Associated with Subcutaneous and Sublingual Allergen Immunotherapy (SCIT and SLIT): AAAAI/ACAAI National Surveillance Study 2008-2015 by Epstein, Tolly, Dr, Liss, Gary M., Dr, Murphy-Berendts, Karen J., Ms, Bernstein, David I., Dr

“…For FDA approved SLIT in 2014-2015 (1355 patients), two Grade 3 SRs were reported, one involving pharyngeal edema and another involving throat tightening and…”
Get full text

Recent Trends in Fatalities, Waiting Times, and Use of Epinephrine Auto-Injectors for Subcutaneous Allergen Immunotherapy (SCIT): AAAAI/ACAAI National Surveillance Study 2008-2016 by Epstein, Tolly, Liss, Gary M., Murphy-Berendts, Karen J., Bernstein, David I.

“…Concerns about SCIT-related infections have not been supported by surveillance data. Despite a high number of delayed SRs, it is not clear that prescription of…”
Get full text

Evaluation of near-fatal reactions to allergen immunotherapy injections by Amin, Hetal S., Liss, Gary M., Bernstein, David I.

“…The overall incidence of near-fatal reactions (NFRs) after immunotherapy injections is unknown. Investigation of NFRs might identify preventive strategies that…”
Get full text

Comparison of Psychological, Quality of Life, Work-Limitation, and Socioeconomic Status Between Patients With Occupational Asthma and Work-Exacerbated Asthma by Lipszyc, Joshua C., Silverman, Frances, Holness, Dorothy Linn, Liss, Gary M., Lavoie, Kim L., Tarlo, Susan M.

“…OBJECTIVE:The aim of this study was to compare psychological status, quality of life (QoL), work limitation, and socioeconomic status between patients with…”
Get full text

Flock worker's lung disease: natural history of cases and exposed workers in Kingston, Ontario by Turcotte, Scott E, Chee, Alex, Walsh, Ronald, Grant, F Curry, Liss, Gary M, Boag, Alexander, Forkert, Lutz, Munt, Peter W, Lougheed, M Diane

“…The natural history of flock worker's lung (FWL) and longitudinal lung function changes in nylon flock-exposed workers have not been well characterized…”
Get full text

Evaluation of the efficacy of a web-based work-related asthma educational tool by Lipszyc, Joshua C., Gotzev, Simeon, Scarborough, Jack, Liss, Gary M., Gupta, Samir, Tarlo, Susan M.

“…Background: Work-related asthma (WRA) has been estimated to account for 15-20% of adult asthma cases. Studies have indicated that a substantial number of…”
Get full text

Evaluation of the risk of infection associated with subcutaneous allergen immunotherapy: American Academy of Allergy, Asthma, and Immunology and American College of Allergy, Asthma, and Immunology National Surveillance Study on Allergen Immunotherapy, 2014-2015 by Epstein, Tolly G, Liss, Gary M, Murphy-Berendts, Karen, Bernstein, David I

Get full text